Getty Images

More states are turning to medical marijuana as an alternative to the addictive prescription painkillers that have driven the public health crisis.

Why it matters: Recent studies found that states with legalized medical marijuana laws have seen lower opioid overdose death rates compared to states that ban it.

By the numbers: 64,000 Americans died from drug overdoses in 2016, about two-thirds of them from heroin, prescription opioids and synthetic opioids, according to the National Center for Health Statistics at the Centers for Disease Control and Prevention.

  • 115 Americans die on average every day from an opioid overdose.
The state of play

New York has expanded the use of medical marijuana as a substitute for an opioid prescription, a move that was first announced last month. This also means that people suffering with from severe pain, which doesn't meet the definition of chronic pain, now qualify to receive medical pot.

  • Overdose deaths involving opioids have increased in New York by roughly 180% from 2010 (over 1,000 deaths) to 2016 (over 3,000 deaths), according to the state's health department.
  • "Adding opioid replacement as a qualifying condition for medical marijuana offers providers another treatment option, which is a critical step in combatting the deadly opioid epidemic affecting people across the state," New York State Health Commissioner Howard Zucker, said in a statement.

Pennsylvania added opioid addiction to the Medical Marijuana Program’s list of qualifying conditions in May. Gov. Tom Wolf also licensed eight universities in the state to conduct clinical research on medical marijuana.

Illinois Gov. Bruce Rauner will soon make a final decision on whether to sign bipartisan legislation, which would allow patients to buy medical pot from licensed dispensaries based on their doctors’ orders, into law.

  • The measure, passed by state lawmakers last month, would cut bureaucratic red-tape by preventing patients from waiting up to four months for approval and being denied access because of past criminal convictions.
  • Take note: A similar measure got vetoed this week in Hawaii by Gov. David Ige.

The big picture: The growing push to swap opioids with medical marijuna comes amid growing tension between state laws permitting recreational and medical marijuana, and the law enforced by the federal government classifying pot as an illegal narcotic.

  • Attorney General Jeff Sessions has directed U.S. attorneys to more aggressively enforce the federal law, increasing confusion over how marijuana can be used in states where it’s legalized and making research about medical benefits more difficult.

Go deeper

Obama: Trump is "jealous of COVID's media coverage"

Former President Barack Obama launched a blistering attack on President Trump while campaigning for Joe Biden in Orlando on Tuesday, criticizing Trump for complaining about the pandemic as cases soar and joking that he's "jealous of COVID's media coverage."

Driving the news: Trump has baselessly accused the news media of only focusing on covering the coronavirus pandemic — which has killed over 226,000 Americans so far and is surging across the country once again — as a way to deter people from voting on Election Day and distract from other issues.

Wisconsin Democrats: Don't return absentee ballots by mail

Signs for Joe Biden are seen outside a home in Coon Valle, Wisconsin, on Oct. 3. Photo by KEREM YUCEL via Getty

Wisconsin Democrats are urging voters to return absentee ballots to election clerks’ offices or drop boxes after a Supreme Court decision on Monday prevented the state from extending its deadline for counting absentee ballots, The New York Times reports.

Why it matters: 1,344,535 of the 1,706,771 Wisconsin voters who requested absentee ballots have returned them, according to the Times. The remaining 366,236 could prove critical in the battleground state, where President Trump won by a thin margin in 2016.

Dan Primack, author of Pro Rata
Updated 2 hours ago - Economy & Business

Winter coronavirus threat spurs new surge of startup activity

Illustration: Sarah Grillo/Axios

U.S. coronavirus cases and hospitalizations are surging, with cold weather arriving before even the best-case scenario for a widely distributed vaccine. Now we're also beginning to see an increase in coronavirus-related startup funding, focused on both testing and pharma.

Driving the news: Gauss, a Silicon Valley computer vision startup focused on health care, tells Axios that it's raised $10 million to accelerate development and commercialization of an at-home rapid antigen test for COVID-19.